SavedAdd your journal

Journals / Türk Geriatri Dergisi / 2013 / Cilt: 16 - Sayı: 2

Anke brakial indeks ve framingham risk skoru 50 yaş ve üzerinde kardiyovasküler hastalıkların bir belirleyicisi midir?

Is ankle brachial index and framingham risk score a predictor of cardiovascular diseases in people aged ≥50 years?

Ruhuşen KUTLU
Hasan Hüseyin ÇELİK
Selma ÇİVİ
Pages
142–149
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In the people aged ≥60 years, ABI risk increase (≤0.95) was found to be 3.878 times greater compared with people aged

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Ankle-Brachial Index (ABI) has been shown to be a strong predictor of the extent and severity of cardiovascular diseases (CVD).
📊
Key Findings & Data:We aimed to determine the early risk estimation of CVD by using ABI and Framingham risk score (FRS) in this study.Materials and Method: In this study, 250 people aged ≥50 years were included.
💡
Conclusion & Impact:In the people aged ≥60 years, ABI risk increase (≤0.95) was found to be 3.878 times greater compared with people aged
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Ankle-Brachial Index (ABI) has been shown to be a strong predictor of the extent and severity of cardiovascular diseases (CVD). We aimed to determine the early risk estimation of CVD by using ABI and Framingham risk score (FRS) in this study.Materials and Method: In this study, 250 people aged ≥50 years were included. We calculated FRS of the participants using an automatic calculator. We calculated ABI by using the blood pressure data of the four extremities.Results: The mean value of ABI was 1.13±0.12 (min=0.80, max=1.96). Of the participants, nine (3.6%) had low ABI (≤0.95). There were significant negative correlations between ABI and age, cigarette smoking, high blood pressure and FRS. In the people aged ≥60 years, ABI risk increase (≤0.95) was found to be 3.878 times greater compared with people aged

Özet

Giriş: Anke Brakial İndeks (ABİ) kardiyovasküler hastalıkların boyutunu ve şiddetini gösteren güçlü bir belirleyicidir. Bu çalışmada ABİ ve Framingham Risk Skoru (FRS) kullanarak kardiyovasküler hastalıkların erken risk tahminini tespit etmeyi amaçladık.Gereç ve Yöntem: Bu çalışmaya 50 yaş ve üzerinde 250 kişi dahil edildi. Katılanların FRS değerleri otomatik olarak hesaplandı. Dört ekstremiteden alınan kan basınçlarını kullanarak ABİ değeri belirlendi.Bulgular: ABİ ortalaması 1.13±0.12 (min=0.80, max=1.96) idi. Katılanların 9'unda (%3.6) ABİ değeri ≤0.95 idi. ABİ ile yaş, sigara içme, yüksek kan basıncı ve FRS arasında önemli derecede negatif korelasyon vardı. 60 yaş ve üzerindeki bireylerde 60 yaş altındakilere göre ABİ'deki risk artımı (≤0.95) 3.878 kez daha fazla idi. Diyabetiklerde FRS1 değeri diyabetik olmayanlara göre 16.349 kez daha fazla idi.Sonuç: Kardiyovasküler hastalıkların temel risk faktörlerine toplumda oldukça sık rastlanır. Kardiyovasküler hastalıkların temel risk faktörlerinin erken tanı ve tedavisi için 50 yaş ve üzerindeki kişilerin taranması gereklidir. Düşük ABİ (≤0.95) ve FRS gelecekte oluşabilecek kardiyovasküler hastalıkların risk tahmininde kullanılabilir.

🔖

Cite This Article

KUTLU, R., ÇELİK, H. H., ÇİVİ, S. (2022). Anke brakial indeks ve framingham risk skoru 50 yaş ve üzerinde kardiyovasküler hastalıkların bir belirleyicisi midir?. Türk Geriatri Dergisi, Cilt: 16 - Sayı: 2, 142–149. https://ajindex.com/articles/623919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Tekin N, Baskan M, Yesilkayali T, Karabay O. Prevalence of peripheral arterial disease and related risk factors in Turkish elders. BMC Fam Pract 2011;12:96-101. (PMID:21929797). Diehm C, Lange S, Darius H, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006;27:1743-9. (PMID:16782720)
  2. Doobay AV, Anand SS. Sensitivity and specificity of the ankle- brachial index to predict future cardiovascular outcomes: a systematic review. Arterioscler Thromb Vasc Biol 2005;25:1463-69. (PMID:15879302)
  3. Fowkes FG, Murray GD, Butcher I. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208. (PMID:18612117)
  4. Fowkes FG, Murray GD, Butcher I. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008;300:197-208. (PMID:18612117)
  5. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease Circulation 2001;104:2673-78. (PMID:11723017)
  6. Feringa HH, Karagiannis SE, Schouten O, Vidakovic R, van Waning VH, Boersma E, Welten G, Bax JJ, Poldermans D. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease. Eur J Vasc Endovasc Surg 2007;34:206-13. (PMID:17481930)
  7. Papamichael CM, Lekakis JP, Stamatelopoulos KS, et al. Ankle-brachial index as a predictor of the extent of coronary atherosclerosis and cardiovascular events in patients with coronary artery disease. Am J Cardiol 2000;86:615-8. (PMID:10980210)
  8. Zheng ZJ, Sharrett AR, Chambless LE, et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke andpreclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 1997;131:115-25. (PMID:9180252). 9. de Ruijter W, Westendorp RG, Assendelft WJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ 2009;338:a3083. (PMID:19131384)
  9. Joint National Committee on Prevention, Evaluation and Treatment of High Blood Pressure. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC 7 Report). National Institutes of Hea